Utama › Karsinoma Sel Skuamosa Kepala dan Leher › California › San Diego
Kajian klinikal Karsinoma Sel Skuamosa Kepala dan Leher di San Diego, CA
14 kajian untuk Karsinoma Sel Skuamosa Kepala dan Leher sedang mencari peserta di lokasi dalam dan sekitar San Diego (dalam lingkungan kira-kira 30 batu). Buka kajian untuk melihat siapa yang layak menyertai dan cara menghubungi pasukan kajian.
Teks kajian rasmi (Bahasa Inggeris)
Mengambil peserta untuk kajian di sini? Paparkan di bahagian atas halaman ini — $99 selama 30 hari →
A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
Mengambil pesertaFasa 1
- University of California, San Diego (UCSD) - Moores Cancer Center, La Jolla · 11 mi jauh
FORTIFI-HN01: A Study of Ficerafusp Alfa (BCA101) or Placebo in Combination With Pembrolizumab in First-Line PD-L1-pos, R or M HNSCC
Mengambil pesertaFasa 2/3
- Site #0107, La Jolla · 11 mi jauh
A First in Human Study of ALX2004 With Advanced or Metastatic Selected Solid Tumors
Mengambil pesertaFasa 1
- ALX Center 9, La Jolla · 11 mi jauh
A Study of Amivantamab in Addition to Standard of Care Agents (SOC) Compared With SOC Alone in Participants With Recurrent/Metastatic Head and Neck Cancer
Mengambil pesertaFasa 3
- Scripps Health, La Jolla · 11 mi jauh
JNJ-90301900 (NBTXR3) Activated by Radiotherapy With or Without Cetuximab in LA-HNSCC
Mengambil pesertaFasa 3
- University of California at San Diego Moores Cancer Center, La Jolla · 11 mi jauh
Intratumoral N17350 in Advanced Solid Tumors
Mengambil pesertaFasa 1/2
- Scripps Clinic Torrey Pines - La Jolla, San Diego
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
Mengambil pesertaKajian pemerhatian
- University of California, San Diego, La Jolla · 11 mi jauh
FT836 With or Without Chemotherapy and/or Monoclonal Antibodies, in Participants With Advanced Solid Tumors
Mengambil pesertaFasa 1
- UC San Diego Moores Cancer Center, La Jolla · 11 mi jauh
Comparing Sentinel Lymph Node (SLN) Biopsy With Standard Neck Dissection for Patients With Early-Stage Oral Cavity Cancer
Mengambil pesertaFasa 2/3
- UC San Diego Medical Center - Hillcrest, San Diego
- UC San Diego Moores Cancer Center, La Jolla · 11 mi jauh
Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patients With Head and Neck Cancer
Mengambil pesertaFasa 2
- UC San Diego Medical Center - Hillcrest, San Diego
- UC San Diego Moores Cancer Center, La Jolla · 11 mi jauh
A Study of Bispecific Antibody MCLA-158 in Patients With Advanced Solid Tumors
Mengambil pesertaFasa 1/2
- Sharp Healthcare, San Diego
- UCSD, La Jolla · 11 mi jauh
A Study to Evaluate the Safety and Efficacy of A2B395, an Allogeneic Logic-gated CAR T, in Participants With Solid Tumors That Express EGFR and Have Lost HLA-A*02 Expression
Mengambil pesertaFasa 1/2
- UCSD Moores Cancer Center, La Jolla · 11 mi jauh
Study of Safety and Tolerability of BCA101 Monotherapy and in Combination Therapy in Patients With EGFR-driven Advanced Solid Tumors
Mengambil pesertaFasa 1
- Moores Cancer Center UC San Diego Health, La Jolla · 11 mi jauh
A Beta-only IL-2 ImmunoTherapY Study
Mengambil pesertaFasa 1/2
- Sharp Memorial Hospital, San Diego
Kajian Karsinoma Sel Skuamosa Kepala dan Leher di bandar lain
- Houston, TX47 kajian
- Los Angeles, CA42 kajian
- Boston, MA40 kajian
- New York City, NY39 kajian
- Nashville, TN39 kajian
- St. Louis, MO28 kajian
- Arlington, VA26 kajian
- Philadelphia, PA26 kajian
- Chicago, IL26 kajian
- Atlanta, GA24 kajian
- San Antonio, TX22 kajian
- New Haven, CT22 kajian
Kajian lain di San Diego
- Kanser Paru-paru Bukan Sel Kecil48 kajian
- Kanser Payudara41 kajian
- Kanser (semua jenis)32 kajian
- Kanser Prostat31 kajian
- Kanser Metastatik30 kajian
- Kanser Kolorektal25 kajian
- Kanser Ovari24 kajian
- Kanser Pankreas24 kajian
- Kanser Paru-paru23 kajian
- Obesiti23 kajian
- Kegagalan Jantung23 kajian
- Depresi21 kajian
Daripada ClinicalTrials.gov, data diperoleh pada 6 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.